vs
Side-by-side financial comparison of 4D Molecular Therapeutics, Inc. (FDMT) and MetroCity Bankshares, Inc. (MCBS). Click either name above to swap in a different company.
4D Molecular Therapeutics, Inc. is the larger business by last-quarter revenue ($85.1M vs $43.7M, roughly 1.9× MetroCity Bankshares, Inc.). MetroCity Bankshares, Inc. runs the higher net margin — 50.5% vs 22.8%, a 27.7% gap on every dollar of revenue. On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs 23.6%). MetroCity Bankshares, Inc. produced more free cash flow last quarter ($37.0M vs $28.5M). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs 15.7%).
4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.
Metro City Bank is a Korean-American bank based in Doraville, Georgia and offers personal and commercial banking services. It is the largest Korean-American bank to not be based out of Los Angeles, California. It currently operates a total of 19 branches in Texas, New York, New Jersey, Virginia, Georgia, Alabama, and Florida.
FDMT vs MCBS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $85.1M | $43.7M |
| Net Profit | $19.4M | $18.1M |
| Gross Margin | — | — |
| Operating Margin | 17.3% | 52.8% |
| Net Margin | 22.8% | 50.5% |
| Revenue YoY | 8508900.0% | 23.6% |
| Net Profit YoY | 139.1% | 11.7% |
| EPS (diluted) | $0.43 | $0.69 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $85.1M | $43.7M | ||
| Q3 25 | $90.0K | $38.0M | ||
| Q2 25 | $15.0K | $37.9M | ||
| Q1 25 | $14.0K | $36.0M | ||
| Q4 24 | $1.0K | $35.4M | ||
| Q3 24 | $3.0K | $36.9M | ||
| Q2 24 | $5.0K | $36.3M | ||
| Q1 24 | $28.0K | $32.7M |
| Q4 25 | $19.4M | $18.1M | ||
| Q3 25 | $-56.9M | $17.3M | ||
| Q2 25 | $-54.7M | $16.8M | ||
| Q1 25 | $-48.0M | $16.3M | ||
| Q4 24 | — | $16.2M | ||
| Q3 24 | $-43.8M | $16.7M | ||
| Q2 24 | $-35.0M | $16.9M | ||
| Q1 24 | $-32.4M | $14.6M |
| Q4 25 | 17.3% | 52.8% | ||
| Q3 25 | -67983.3% | 62.8% | ||
| Q2 25 | -396373.3% | 62.4% | ||
| Q1 25 | -383007.1% | 61.3% | ||
| Q4 24 | — | 58.9% | ||
| Q3 24 | -1704400.0% | 61.4% | ||
| Q2 24 | -849120.0% | 64.4% | ||
| Q1 24 | -136200.0% | 62.6% |
| Q4 25 | 22.8% | 50.5% | ||
| Q3 25 | -63195.6% | 45.5% | ||
| Q2 25 | -364386.7% | 44.4% | ||
| Q1 25 | -342657.1% | 45.3% | ||
| Q4 24 | — | 54.0% | ||
| Q3 24 | -1461433.3% | 45.3% | ||
| Q2 24 | -699060.0% | 46.7% | ||
| Q1 24 | -115717.9% | 44.8% |
| Q4 25 | $0.43 | $0.69 | ||
| Q3 25 | $-1.01 | $0.67 | ||
| Q2 25 | $-0.98 | $0.65 | ||
| Q1 25 | $-0.86 | $0.63 | ||
| Q4 24 | — | $0.64 | ||
| Q3 24 | $-0.79 | $0.65 | ||
| Q2 24 | $-0.63 | $0.66 | ||
| Q1 24 | $-0.66 | $0.57 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $402.7M | $383.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $505.7M | $544.2M |
| Total Assets | $566.7M | $4.8B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $402.7M | $383.7M | ||
| Q3 25 | $305.1M | $227.2M | ||
| Q2 25 | $293.2M | $286.0M | ||
| Q1 25 | $321.4M | $285.1M | ||
| Q4 24 | $424.9M | $249.9M | ||
| Q3 24 | $501.9M | $291.2M | ||
| Q2 24 | $541.9M | $327.9M | ||
| Q1 24 | $525.9M | $258.8M |
| Q4 25 | $505.7M | $544.2M | ||
| Q3 25 | $369.0M | $445.9M | ||
| Q2 25 | $420.9M | $436.1M | ||
| Q1 25 | $469.7M | $428.0M | ||
| Q4 24 | $510.6M | $421.4M | ||
| Q3 24 | $552.9M | $407.2M | ||
| Q2 24 | $588.3M | $407.2M | ||
| Q1 24 | $600.6M | $396.6M |
| Q4 25 | $566.7M | $4.8B | ||
| Q3 25 | $424.0M | $3.6B | ||
| Q2 25 | $473.6M | $3.6B | ||
| Q1 25 | $515.7M | $3.7B | ||
| Q4 24 | $560.4M | $3.6B | ||
| Q3 24 | $604.0M | $3.6B | ||
| Q2 24 | $620.1M | $3.6B | ||
| Q1 24 | $629.9M | $3.6B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.6M | $37.7M |
| Free Cash FlowOCF − Capex | $28.5M | $37.0M |
| FCF MarginFCF / Revenue | 33.5% | 84.7% |
| Capex IntensityCapex / Revenue | 0.1% | 1.5% |
| Cash ConversionOCF / Net Profit | 1.47× | 2.08× |
| TTM Free Cash FlowTrailing 4 quarters | $-109.9M | $79.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $28.6M | $37.7M | ||
| Q3 25 | $-46.5M | $16.5M | ||
| Q2 25 | $-43.4M | $14.5M | ||
| Q1 25 | $-47.8M | $11.9M | ||
| Q4 24 | $-134.6M | $63.5M | ||
| Q3 24 | $-29.4M | $-11.5M | ||
| Q2 24 | $-30.2M | $19.4M | ||
| Q1 24 | $-29.1M | $36.4M |
| Q4 25 | $28.5M | $37.0M | ||
| Q3 25 | $-46.6M | $16.2M | ||
| Q2 25 | $-43.4M | $14.3M | ||
| Q1 25 | $-48.4M | $11.8M | ||
| Q4 24 | $-138.4M | $62.2M | ||
| Q3 24 | $-31.2M | $-11.8M | ||
| Q2 24 | $-30.6M | $19.0M | ||
| Q1 24 | $-29.8M | $36.1M |
| Q4 25 | 33.5% | 84.7% | ||
| Q3 25 | -51765.6% | 42.7% | ||
| Q2 25 | -289620.0% | 37.8% | ||
| Q1 25 | -345635.7% | 32.9% | ||
| Q4 24 | -13837100.0% | 175.8% | ||
| Q3 24 | -1038966.7% | -31.9% | ||
| Q2 24 | -611840.0% | 52.4% | ||
| Q1 24 | -106421.4% | 110.6% |
| Q4 25 | 0.1% | 1.5% | ||
| Q3 25 | 101.1% | 0.7% | ||
| Q2 25 | 440.0% | 0.3% | ||
| Q1 25 | 4507.1% | 0.2% | ||
| Q4 24 | 378600.0% | 3.6% | ||
| Q3 24 | 59266.7% | 0.8% | ||
| Q2 24 | 6980.0% | 1.0% | ||
| Q1 24 | 2535.7% | 0.7% |
| Q4 25 | 1.47× | 2.08× | ||
| Q3 25 | — | 0.95× | ||
| Q2 25 | — | 0.86× | ||
| Q1 25 | — | 0.73× | ||
| Q4 24 | — | 3.91× | ||
| Q3 24 | — | -0.69× | ||
| Q2 24 | — | 1.14× | ||
| Q1 24 | — | 2.49× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
